MAPK variant effect atlas
Proteins / CRAF

CRAF

RAF proto-oncogene serine/threonine-protein kinase · gene RAF1

RAF kinase UniProt P04049 HSP90 client (literature): strong 3D structure ↓ 35 interaction partners · volcano ↗
Mutagenized 2–335Mutagenized 337–648RBD 56–131RBDCRD 138–184CRDKinase 349–609Kinase1648 aagrey box: mutagenized region

MAPK pathway activity (phosphorylated ERK2 reporter) under basal conditions. Scores are WT-relative: 1 = wild type.

14,033 variantsmissense decreased 36% · increased 24%526 dominant negative variants
Other cells fade; highlighted cells are outlined.
Annotation tracks
Structure
Function
Chaperone
Variant effect
Track legend & definitions
Secondary structure
alpha helix3-10 helixpi helixbeta strandbeta bridgeturnbendno_ss
DSSP assignment on the reference structure.
Relative SASA
0.000.250.500.751.00
Side-chain solvent accessibility (0 = buried, 1 = fully exposed). The pipeline calls a residue surface-exposed above 0.25.
pLDDT
50.062.575.087.5100.0
AlphaFold per-residue confidence. The analysis drops residues below 60.
Curated feature
Protein-protein interfaceCatalytic / active siteLigand / substrate pocketRegulatory elementOther annotation
UniProt / literature annotation, coloured by class. Red marks a curated protein-protein interface — the independent comparison for our predicted interfaces.
Annotated interface
yesno
Curated protein-interface residue, independent of any structure prediction in this study.
Active site
yesno
Curated catalytic / active-site residue.
Inter-domain contact
yesno
Residue contacting another domain of the same protein (all-atom), so a variant effect there may be intramolecular rather than at a PPI.
HSP90 contact
TrueFalseUnknown
Contacts HSP90 in the chaperone-client cryo-EM structures ('Unknown' where the protein was not mapped).
CDC37 contact
TrueFalseUnknown
Contacts CDC37. These positions report kinase foldability rather than a canonical binding surface.
Fraction decreased
0%25%50%75%100%
Fraction of variants at this position classified decreased in this assay (2.5th-percentile rule).
Fraction increased
0%25%50%75%100%
Fraction of variants at this position classified increased in this assay.
Fraction dominant-negative
0%25%50%75%100%
Fraction of variants at this position called dominant negative: basal pathway activity below the empty-vector threshold (basal activity only).
Domain Secondary structure Relative SASA pLDDT Curated feature Annotated interface Active site Inter-domain contact HSP90 contact CDC37 contact Fraction decreased Fraction increased Fraction dominant-negative Interface A V I L G F Y W C M P S T N Q D E H K R * -
RBD CRD Kinase 20 40 60 80 100 120 140 160 180 200 220 240 260 280 300 320 340 360 380 400 420 440 460 480 500 520 540 560 580 600 620 640 0.19 1.00 2.35
Click a position for its interactions and annotations — ■ the Interface strip marks positions in ≥1 supported interface (darker = more partners)

Structure · CRAF alone

Loading 3D viewer…

Interfaces of CRAF

One row per interface: complexes of the same pair and source whose interfaces overlap (IoU ≥ 0.3) are merged, as in the Fig. 6c,d volcano plots (median Cohen's d; q from the geometric-mean p). Supported: at least one complex with q < 0.05 and |d| ≥ 0.2 in either basal assay.

PartnerSourceActivity dq Abundance dqInterface positionsSupported
KSR2AF-M-1.215.9e-62+0.010.41112supportedStructure ↗
CLEC16AAF-M-1.444.2e-54-0.120.0058supportedStructure ↗
RAP1BAF-M-0.911.1e-43+0.331.3e-0413supportedStructure ↗
KSR1AF-M-0.813.9e-43+0.060.17113supportedStructure ↗
ARAFAF-M-0.941.3e-39+0.040.34214supportedStructure ↗
CDC37PDB-1.001.0e-33-1.071.8e-3412supportedStructure ↗
BRAFAF-M-0.951.3e-33-0.265.1e-0411supportedStructure ↗
STK3
STKc_C-Raf #2
AF-M-2.046.6e-32+0.110.9633supportedStructure ↗
GNB1RF2-PPI-0.755.1e-28+0.200.00311supportedStructure ↗
RAP1APDB-1.211.8e-26+0.110.2527supportedStructure ↗
GNB2AF-M-1.067.5e-25-0.160.0166supportedStructure ↗
KRASPDB-1.161.1e-24+0.090.1387supportedStructure ↗
NRASAF-M-0.548.5e-23+0.251.6e-0514supportedStructure ↗
KRASAF-M-0.531.1e-22+0.243.1e-0514supportedStructure ↗
RAP1AAF-M-0.602.2e-22+0.312.0e-0410supportedStructure ↗
PPP1CBRF2-PPI+1.912.7e-22-0.504.2e-077supportedStructure ↗
HRASPDB-1.145.3e-22+0.150.0156supportedStructure ↗
MRASAF-M-0.623.9e-21+0.212.1e-0410supportedStructure ↗
RRAS2AF-M-0.531.1e-20+0.221.5e-0413supportedStructure ↗
HRASAF-M-0.531.1e-19+0.251.3e-0414supportedStructure ↗
YWHAB
res 142-611
AF-M+2.005.5e-18-0.429.0e-057supportedStructure ↗
YWHAB
STKc_C-Raf
AF-M+1.020.075-0.675.6e-1710supportedStructure ↗
RAP2AAF-M-0.585.7e-15+0.371.8e-058supportedStructure ↗
SFN
C1_A_C-Raf
AF-M+1.624.4e-12-0.493.0e-089supportedStructure ↗
HSP90AB1PDB-0.020.002-0.556.8e-106supportedStructure ↗
NDUFA10
res 94-522
AF-M+0.343.2e-07+0.351.1e-0921supportedStructure ↗
TAOK1AF-M-0.423.3e-09-0.140.0099supportedStructure ↗
MAP2K6AF-M-0.375.0e-09-0.301.7e-069supportedStructure ↗
GNB2RF2-PPI-0.471.5e-08+0.220.0119supportedStructure ↗
MAP2K3AF-M-0.344.3e-08-0.312.2e-069supportedStructure ↗
NR3C1
C1_A_C-Raf
AF-M-0.596.6e-08-0.010.4825supportedStructure ↗
MAP3K1AF-M-0.341.5e-07-0.200.0067supportedStructure ↗
MEK1PDB-0.081.2e-04-0.278.4e-0718supportedStructure ↗
MEK1RF2-PPI-0.332.7e-06-0.251.4e-049supportedStructure ↗
MAP2K5AF-M-0.295.1e-06-0.268.0e-0610supportedStructure ↗
A0A1B0GUL7RF2-PPI-0.282.3e-04-0.272.1e-047supportedStructure ↗
CSNK1G1AF-M+0.897.4e-04-0.257.0e-0410supportedStructure ↗
JAK2AF-M-0.237.1e-04-0.030.50313supportedStructure ↗
MEK1AF-M-0.200.001-0.050.12713supportedStructure ↗
NR3C1
STKc_C-Raf
AF-M+0.090.686-0.270.0026supportedStructure ↗
SFN
res 612-622
AF-M-0.250.047-0.300.0034supportedStructure ↗
STK3
STKc_C-Raf
AF-M-0.280.007-0.250.0054supportedStructure ↗
LSM14AAF-M+0.480.027-0.240.0554supportedStructure ↗
LOC113496266PDB-0.220.046-0.030.8276supportedStructure ↗
MEK2RF2-PPI-0.050.298-0.160.00118not supportedStructure ↗
MEK2AF-M-0.110.009-0.130.01316not supportedStructure ↗
NDUFA10
C1_A_C-Raf
AF-M+0.450.055+0.130.3515not supportedStructure ↗